---
title: "Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295539574.md"
description: "New research has reinforced the efficacy of Cingulate's Precision Timed Release™ (PTR™) platform and its three-pronged drug delivery system. The study underscores the platform's effectiveness in delivering medication with precision timing. This validation adds to the growing body of evidence supporting PTR™, which has demonstrated remarkable outcomes in drug delivery. The findings highlight the platform's potential to enhance the targeted release of medications, offering a promising solution for optimized treatment."
datetime: "2026-08-11T12:33:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295539574.md)
  - [en](https://longbridge.com/en/news/295539574.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295539574.md)
generator: "portal-rs"
---

# Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile

New research has reinforced the efficacy of Cingulate's Precision Timed Release™ (PTR™) platform and its three-pronged drug delivery system. The study underscores the platform's effectiveness in delivering medication with precision timing. This validation adds to the growing body of evidence supporting PTR™, which has demonstrated remarkable outcomes in drug delivery. The findings highlight the platform's potential to enhance the targeted release of medications, offering a promising solution for optimized treatment.

### Related Stocks

- [CING.US](https://longbridge.com/en/quote/CING.US.md)
- [CINGW.US](https://longbridge.com/en/quote/CINGW.US.md)

## Related News & Research

- [Cingulate price target lowered to $9 from $10 at Roth Capital](https://longbridge.com/en/news/296734582.md)
- [Cingulate publishes peer-reviewed pharmacokinetic study of ADHD candidate CTx-1301 in CNS Drugs](https://longbridge.com/en/news/295537403.md)
- [Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing](https://longbridge.com/en/news/297194419.md)
- [Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs | DTCFF Stock News](https://longbridge.com/en/news/297476847.md)
- [BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines | ONC Stock News](https://longbridge.com/en/news/297552849.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**